Emergency medicine misconceptions: Utility of routine coagulation panels in the emergency department setting

Background: Coagulation panels are ordered for a variety of conditions in the emergency department (ED). Objective: This narrative review evaluates speci fic conditions for which a coagulation panel is commonly ordered but has limited utility in medical decision -making. Discussion: Coagulation panels consist of partial thromboplastin time (PTT) or activated partial thromboplastin time (aPTT), prothrombin time (PT), and international normalized ratio (INR). These tests evaluate the coagula- tion pathway which leads to formation of a fibrin clot. The coagulation panel can monitor warfarin and heparin therapy, evaluate for vitamin K de ficiency, evaluate for malnutrition or severe systemic disease, and assess hemo- static function in the setting of bleeding. The utility of coagulation testing in chest pain evaluation, routine peri- operative assessment, prior to initiation of anticoagulation, and as screening for admitted patients is low, with little to no change in patient management based on results of these panels. Coagulation testing should be consid- ered in systemically ill patients, those with a prior history of bleeding or family history of bleeding, patients on anticoagulation, or patients with active hemorrhage and signs of bleeding. Thromboelastography and rotational thromboelastometry offer more reliable measures of coagulation function. Conclusions: Little utility for coagulation assessment is present for the evaluation of chest pain, routine perioper- ative assessment, initiation of anticoagulation, and screening for admitted patients. However, coagulation panel assessment should be considered in patients with hemorrhage, patients on anticoagulation, and personal history or family history of bleeding.